How is the Inflammatory Bowel Disease Treatment Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the inflammatory bowel disease treatment market grown in recent years?
The market size for treatment of inflammatory bowel disease has seen substantial expansion in the past few years. The projection is that it will escalate from $25.26 billion in 2024 to $27.45 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. The surge during the historic period can be accredited to factors such as a surge in cases of inflammatory bowel disease, escalating demand for biologics and immunomodulators, advancements in treatment modalities, an aging population, and heightened cognizance about the disease.
How is the inflammatory bowel disease treatment market size expected to evolve during the forecast period?
In the coming years, the market size for the treatment of inflammatory bowel disease is predicted to witness a swift expansion. By 2029, it is expected to reach a staggering value of $40.27 billion, progressing at a compound annual growth rate (CAGR) of 10.1%. Several factors can be credited for the projected growth during this period including the increasing investment in research and development, a surging demand for biosimilars and personalized medicine, higher incidences of inflammatory bowel disease in emerging markets and the application of precision medicine in treating IBD. Upcoming trends anticipated during this forecast period comprise an augmenting number of product launches and approvals, customization of treatment regimes and dosages for managing IBD, the employment of telemedicine to remotely monitor IBD patients, introduction of microbiome-based therapies for treating IBD, and the integration of value-based care models in the treatment of IBD.
Get your inflammatory bowel disease treatment market report here!
Which key drivers are propelling the inflammatory bowel disease treatment market’s growth?
The surge in cases of Crohn’s disease and ulcerative colitis is a significant factor propelling the growth of the market for inflammatory bowel disease treatment. These two conditions are forms of inflammatory bowel diseases (IBD) which lead to inflammation and ulceration (sores) in the digestive system. The increase in instances of Crohn’s disease and ulcerative colitis is anticipated to enhance the demand for therapeutic solutions for inflammatory bowel disease, as they are commonly employed to decrease inflammation within the bowel and mitigate and avert health-related complications. For instance, research conducted in the United States National Library of Medicine in March 2022 reports that approximately 1.6 million Americans currently live with inflammatory bowel disease (either Crohn’s disease or ulcerative colitis), and about 70,000 fresh instances of IBD are identified annually in the USA. Therefore, the escalating occurrence of Crohn’s disease and ulcerative colitis is projected to fuel the progression of the inflammatory bowel disease treatment market.
What are the market segments in the inflammatory bowel disease treatment industry?
The inflammatory bowel disease treatment market covered in this report is segmented –
1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes
2) By Type: Crohn’s Disease, Ulcerative Colitis
3) By Route Of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide
2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone
3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol
4) By IL Inhibitors: Ustekinumab, Guselkumab
5) By Anti-Integrin: Vedolizumab, Natalizumab
6) By JAK Inhibitors: Tofacitinib, Filgotinib
7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp
Which leading companies are shaping the growth of the inflammatory bowel disease treatment market?
Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.
What key trends are currently impacting the inflammatory bowel disease treatment market’s development?
The inflammatory bowel disease treatment market is increasingly witnessing the influence of technology as a key growing trend. Major entities in the market are leveraging AI-based registry to seek a competitive advantage. For instance, in May 2024, Verantos, a company based in California specializing in real-world evidence (RWE), unveiled the Inflammatory Bowel Disease Pragmatic Registry. This is powered by state-of-the-art artificial intelligence and provides high-quality real-world evidence for ulcerative colitis and Crohn’s disease. The objective of this registry is to aid in developing effective therapies by offering an expansive dataset of over 3 billion data points regarding patient care. It grants biopharma researchers the ability to delve deeper into aspects like disease severity, treatment efficacy, and clinical outcomes by using both organized and unorganized data from electronic healthcare records.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6704
Which geographic areas are influencing the growth of the inflammatory bowel disease treatment market?
North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Microbiome Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report
Digestive Enzymes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report
C-Reactive Protein Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
